Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I don't think it has anything to do with a broker whether or not they lend out your stock... but rather it has to do with your account.
If you have a margin account then you can bet your A$$ they are lending out your stock... especially if they are getting 20, 30, 40% on it... but if it's a CASH account then they CAN NOT lend your shares out without your permission.
IRAs... Roth or SEP can only be a cash accounts... personal accounts can be either or.
You can turn a margin account to a cash account anytime you want to... but of course if you do, all stocks must be fully paid for.
But after all is said and done... I don't believe they honor those rules... if they have a stock that they can lend out in any account I believe they will.
Hell... some brokers even lend out stock they don't have - you know - Naked Shorting... and I think most, if not all do it.
If I had $10 million dollars... I would approach Odidi with an offer to take it private now... and the way his "first round" investors speak of him... I'm not sure he wouldn't accept.
Sentencing tomorrow
Facts become history... history becomes fables... fables become myths... myths become legend.
It seems to me that up until today... the China curriculum was seen as a positive thing for IPCI and all it's shareholders.
What has happened that seems to have changed your mind???
Another typical day on the IPCI message board ... nothing but shorts spreading FUD in order to bring the price down.
Somewhat off topic
"Pharma Bro" Martin Shkreli (SHKREL'-ee) has written a letter to a judge asking for leniency and admitting that he was wrong and a fool.
https://www.msn.com/en-us/news/us/pharma-bro-asks-judge-for-leniency-saying-he-was-a-fool/ar-BBJIumZ?li=BBnbfcL&ocid=spartandhp
Saw a documentary on this A$$ &%#^ what a disgusting excuse of a human being... I hope the judge takes the sentence time... and multiplies it by 5000%!!!
Seems like total market for Seroquel XR has dropped from $1.2 billion to $557 million now that it has gone generic.
Lamictal XR @ $531 million and Prestiq @ $582 million are already genericized... so total market for these 3 generic drugs is $1.67 BILLION.
Each percentage point equals $16.7 million x a 30% royalty basis equals $5 million revenue to IPCI per %age point.
For gods sake... 2.5% penetration makes us profitable.
It's just a matter of time... HANG IN THERE!!!
Updated Spread Sheet - Open for interpretation.
Seems like we settled into a rather mediocre sales performance.
Would be great if someone could utilize the data and ascertain a royalty percentage for Seroquel XR... if 30% to 40% then our woes can be readily fixed within one quarter IF MNK performed for us as well as they do for themselves... one quarter of sales where MNK captures their rightful share... which in my opinion is approx. 10% ... and we'd be off to the races.
They (MNK) are up over $5.00 a share in 15 minutes - that's $500 million market cap added - now if they would only take 40% of today's market cap gain and make an offer Odidi couldn't refuse.
I wouldn't mind an all stock offer.
WOW!!!
Mallinckrodt Reports Q4 EPS $2.01 vs $1.69 Est., Sales $792M vs $774M Est
They have 95 million shares so a profit of almost $200 million for the quarter.
Let's see... IPCI has ~ 40 million fully diluted shares - so $5.00 a share would be just about right.
No reason to even speculate on delisting NOW - because mid march they can apply for a 6 month extension... and I see absolutely no reason what-so-ever why they would not be granted that.
Six months in the life of an emerging biotech can be transformational.
Just as it has gone from $3+ to 60 cents... it can as readily go from 60 cents to $3+...
Furthermore... everyone here knows that, which is why they are still here... or they would be gone!!!
Thanxs Fabius
Have numbers plugged in... but need sale #s also for the below.
last numbers I have on the TRX numbers are Dec 8th @ 639 and Dec 15th @ 648
need Seroquel XR Weekly Sales TRXs - since December 8, 2017
I have absolutely no idea how generic marketing works... nor that MNK is not doing well marketing Seroquel because of locked in contracts.
I'm only guessing but it is a possibility that MNK has interest in IPCI and by dragging ass on Seroquel they are driving down possible takeover price... amiable or hostile... but again just brain farts.
At one time when IPCI expressed some interest in possibly becoming a distributor themselves I feared they would have to dilute and incur much expense which would push back break even point.
Now I wish they would have issued 10 million shares when stock was $3+ and gone that route.